These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34439875)

  • 1. Histatin 5 Metallopeptides and Their Potential against
    Zolin GVS; Fonseca FHD; Zambom CR; Garrido SS
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection.
    Peters BM; Zhu J; Fidel PL; Scheper MA; Hackett W; El Shaye S; Jabra-Rizk MA
    FEMS Yeast Res; 2010 Aug; 10(5):597-604. PubMed ID: 20491938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary Histatin 5 Level in Women with Vaginal Candidiasis.
    Şenyuva İ; Koca C; Karabag Çoban F; Tarhan Ö
    Int J Clin Pract; 2022; 2022():5279323. PubMed ID: 35832797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.
    Gyurko C; Lendenmann U; Helmerhorst EJ; Troxler RF; Oppenheim FG
    Antonie Van Leeuwenhoek; 2001 Sep; 79(3-4):297-309. PubMed ID: 11816973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
    Curvelo JAR; Moraes DC; Anjos CAD; Portela MB; Soares RMA
    An Acad Bras Cienc; 2019; 91(1):e20180045. PubMed ID: 30994755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of Candida albicans in human saliva is supported by low-molecular-mass compounds.
    Valentijn-Benz M; Nazmi K; Brand HS; van't Hof W; Veerman EC
    FEMS Yeast Res; 2015 Dec; 15(8):. PubMed ID: 26392045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.
    Gyurko C; Lendenmann U; Troxler RF; Oppenheim FG
    Antimicrob Agents Chemother; 2000 Feb; 44(2):348-54. PubMed ID: 10639361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA; Reis de Sá LF; Moraes DC; Soares RM; Ferreira-Pereira A
    J Mycol Med; 2018 Mar; 28(1):137-142. PubMed ID: 29217144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.
    Ikonomova SP; Moghaddam-Taaheri P; Jabra-Rizk MA; Wang Y; Karlsson AJ
    FEBS J; 2018 Jan; 285(1):146-159. PubMed ID: 29143452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva affects the antifungal activity of exogenously added histatin 3 towards Candida albicans.
    Yamagishi H; Fitzgerald DH; Sein T; Walsh TJ; O'Connell BC
    FEMS Microbiol Lett; 2005 Mar; 244(1):207-12. PubMed ID: 15727842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between Candida albicans and the antimicrobial peptide armory.
    Swidergall M; Ernst JF
    Eukaryot Cell; 2014 Aug; 13(8):950-7. PubMed ID: 24951441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An acquired mechanism of antifungal drug resistance simultaneously enables Candida albicans to escape from intrinsic host defenses.
    Hampe IAI; Friedman J; Edgerton M; Morschhäuser J
    PLoS Pathog; 2017 Sep; 13(9):e1006655. PubMed ID: 28953977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5.
    Nikawa H; Jin C; Makihira S; Hamada T; Samaranayake LP
    J Prosthet Dent; 2002 Sep; 88(3):263-7. PubMed ID: 12426495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Candida dubliniensis to salivary histatin 3.
    Fitzgerald DH; Coleman DC; O'Connell BC
    Antimicrob Agents Chemother; 2003 Jan; 47(1):70-6. PubMed ID: 12499171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans.
    Edgerton M; Koshlukova SE; Lo TE; Chrzan BG; Straubinger RM; Raj PA
    J Biol Chem; 1998 Aug; 273(32):20438-47. PubMed ID: 9685398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding, internalisation and degradation of histatin 3 in histatin-resistant derivatives of Candida albicans.
    Fitzgerald DH; Coleman DC; O'Connell BC
    FEMS Microbiol Lett; 2003 Mar; 220(2):247-53. PubMed ID: 12670688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary histatin-5 and oral fungal colonisation in HIV+ individuals.
    Torres SR; Garzino-Demo A; Meiller TF; Meeks V; Jabra-Rizk MA
    Mycoses; 2009 Jan; 52(1):11-5. PubMed ID: 18983435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.
    Tsai H; Bobek LA
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2224-8. PubMed ID: 9333052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.